3.4 Residual Kidney Function, Incremental Hemodialysis, and Adequacy Beyond Kt/V

3.4 Residual Kidney Function, Incremental Hemodialysis, and Adequacy Beyond Kt/V

Quick Summary: Residual kidney function (RKF) is the native clearance a dialysis patient still has. It is measured by a timed urine collection, usually 24 hours, and expressed as residual renal urea clearance (Kru) in mL/min. RKF independently predicts survival, permits reduced dialysis prescriptions, and is destroyed by the very hemodynamic stress that aggressive ultrafiltration creates.

Why an Advanced Technician Needs This

The monthly adequacy report shows spKt/V and URR. Both describe dialyzer clearance only. A patient who arrives with 900 mL of daily urine at the start of the year and 100 mL by December may have an identical spKt/V of 1.5 in January and December, while total weekly solute removal, phosphate control, potassium tolerance, and fluid latitude have all collapsed. The technician who notices that a patient's interdialytic weight gains have crept from 1.4 kg to 3.6 kg over four months, and who reports it, is detecting the loss of residual function before the laboratory does.

Measuring Residual Function

Residual clearance cannot be inferred from a serum creatinine, because dialysis dictates the serum level. It requires a timed urine collection over the interdialytic interval - most commonly a 24-hour urine collection - paired with a serum urea (and often creatinine) drawn at the midpoint of the collection.

$K_{ru} = \frac{U_{urea} \times V_{urine}}{P_{urea} \times t}$

where U is urine urea concentration, V is total collected volume, P is the plasma urea concentration, and t is the collection time in minutes.

Worked example. A patient collects 1,200 mL of urine over 24 hours. Urine urea nitrogen is 480 mg/dL and the midpoint serum urea nitrogen is 48 mg/dL.

• Urine urea excreted = 480 mg/dL x 12 dL = 5,760 mg over 1,440 minutes.
• Excretion rate = 5,760 mg / 1,440 min = 4.0 mg/min.
• Kru = 4.0 mg/min / 48 mg/dL = 4.0 / 0.48 mg/mL = 8.3 mL/min.

That is a clinically substantial residual clearance and would ordinarily support a reduced treatment schedule.

Distractor discipline. On the examination, options offering a random urinalysis, a spot urine for glucose, or a urine culture and sensitivity are all real tests that answer entirely different questions - proteinuria and sediment, glycosuria, and infection respectively. Only a timed (24-hour) urine collection measures residual kidney function.

Collection integrity matters: the patient discards the first void to start the clock, collects every subsequent void including the final timed void, and keeps the container refrigerated. A single missed void invalidates the study and produces a falsely low result that could push a patient onto an unnecessarily intensive schedule.

Contribution to Total Clearance

Residual clearance is continuous - 10,080 minutes per week - whereas dialysis is intermittent. Continuous clearance is therefore far more valuable per mL/min than intermittent clearance. As a working rule, each 1 mL/min of Kru adds approximately 0.2 to 0.3 units of weekly standardized Kt/V (stdKt/V). A patient with 5 mL/min of Kru carries roughly 1.0 to 1.5 stdKt/V units of native clearance before the dialyzer is even connected.

Residual function also delivers benefits no dialyzer replicates:

• Volume latitude. Urine output blunts interdialytic weight gain, permitting lower ultrafiltration rates.
• Middle-molecule and protein-bound solute clearance. Native nephrons clear beta-2 microglobulin and protein-bound uremic toxins that diffusive dialysis clears poorly.
• Phosphate and potassium handling, reducing binder burden and arrhythmia risk.
• Endocrine function - residual erythropoietin production and 1-alpha hydroxylation of vitamin D.

Incremental Hemodialysis

Incremental hemodialysis matches the prescription to total clearance rather than starting every incident patient at thrice weekly for four hours. A typical pathway:

Escalation triggers a technician can see at the chair: interdialytic weight gain climbing above 4-5% of estimated dry weight, refractory hypertension, pre-dialysis potassium creeping upward, new dyspnea on the interdialytic day, or a patient reporting that urine output has fallen off. Each of these belongs in the treatment record and in a report to the nurse.

Protecting What Remains

Residual function is lost through repeated ischemic insults to marginally perfused nephrons, and hemodialysis itself is a leading cause.

Practices that preserve RKF:

• Keep the ultrafiltration rate below 13 mL/kg/hr; higher rates cause the same hypoperfusion that stuns myocardium and kidney alike.
• Prevent intradialytic hypotension. Every symptomatic hypotensive episode is a renal ischemic event.
• Set the estimated dry weight conservatively rather than chasing an aggressive target.
• Report any planned exposure to iodinated contrast, aminoglycosides, or NSAIDs so the team can weigh alternatives.
• Support blood pressure medications that preserve renal perfusion, and never encourage a patient to skip them without team direction.
• Use high-flux, biocompatible membranes and ultrapure dialysate, which are associated with slower RKF decline.
• Reinforce that residual urine output means the patient's fluid restriction is more generous than their anuric neighbor's - a message that improves adherence rather than eroding it.

Practices that destroy it: aggressive dry-weight reduction, short high-UFR treatments, repeated hypotension, unreported nephrotoxin exposure, and untreated obstructive or infectious complications.

Charting the Story

When a patient with residual function is treated, the record should show urine output as reported by the patient, interdialytic weight gain trend, ultrafiltration volume and rate, any hypotensive episodes and interventions, and symptom changes. Over several months this record is what lets the interdisciplinary team distinguish true RKF decline from a transient illness - and it is the technician who produces it.